STEPHANIE JOHNSTON: Open Payments
NPI 1407229628 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 60 payments from 25 companies in 2025. Trend: 2023 $6,281 · 2024 $2,294 · 2025 $1,485
Food & beverage: $1,306Education: $179
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $206 |
| Gilead Sciences, Inc. | 5 | $113 |
| PFIZER INC. | 4 | $108 |
| Aveo Pharmaceuticals, Inc. | 2 | $108 |
| SOBI, INC | 4 | $92 |
| Incyte Corporation | 4 | $90 |
| Celgene Corporation | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| SERVIER PHARMACEUTICALS LLC | 3 | $68 |
| Eisai Inc. | 3 | $67 |
Products named: Trodelvy, FOTIVDA, REBLOZYL, IMFINZI, LYNPARZA, Lenvima, Doptelet, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
